Find expertise
Biocrystallography KU Leuven
The design of new potential drugs is traditionally the domain of the pharmacochemist. In the last decades Quantitative Structure-Activity Relationship (QSAR)-techniques are used more and more to define the 'essential' moieties of a pharmacon. A logical evolution in the search for the relation between the 3D-structure of drugs & their biological activity is the 3D-structure analysis of the biological target molecules and the receptor- ...
Sergei Strelkov KU Leuven
Katerina Cermakova KU Leuven
Jan De Rijck KU Leuven
Sara Elashkar KU Leuven
Tine Brouns KU Leuven
Molecular Virology and Gene Therapy KU Leuven
The division Molecular Virology and Gene Therapy aims at developing novel therapeutics and diagnostics starting from basic research into the molecular cause of disease and employing the most advanced biomedical technologies. Research can be basic, applied or technological; in all cases our research aims at future applications in medicine.
Major disease areas are AIDS and Parkinson's disease. Other interests are gene therapy of cystic ...